Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,26406,25,4.22 [2.26-7.89],6.320829258000262e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACTA2,"Actin, aortic smooth muscle",25852,25,2.35 [1.65-3.36],2.550544734969573e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADA2,Adenosine deaminase 2,26138,24,6.65 [3.84-11.52],1.3772521234639932e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,26148,22,8.32 [3.49-19.87],1.813893077354076e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,22768,18,4.92 [2.51-9.63],3.2942687751934707e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRB3,Adhesion G protein-coupled receptor B3,26105,22,9.41 [3.62-24.41],4.11079515716786e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRE5,Adhesion G protein-coupled receptor E5,26491,25,7.02 [3.63-13.57],6.7285088198741805e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,26210,25,2.46 [1.82-3.33],4.8682545833652674e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AREG,Amphiregulin,26210,25,2.82 [1.88-4.24],6.001383100184741e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ART3,Ecto-ADP-ribosyltransferase 3,26390,25,7.40 [3.85-14.22],1.868320788533993e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",22230,18,7.70 [3.17-18.69],6.362328523378121e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA12,Carbonic anhydrase 12,26210,25,4.88 [3.40-7.01],8.981266032490119e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA14,Carbonic anhydrase 14,26556,25,6.96 [3.41-14.19],9.326089486040904e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA4,Carbonic anhydrase 4,26642,25,9.93 [4.87-20.22],2.566977883175972e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA9,Carbonic anhydrase 9,26556,25,3.40 [2.08-5.55],9.94490816996539e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CALB1,Calbindin,26210,25,4.38 [2.77-6.91],2.4072715421580527e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CBLIF,Cobalamin binding intrinsic factor,26289,24,2.61 [1.72-3.96],7.051213271806329e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL15,C-C motif chemokine 15,26642,25,4.56 [2.72-7.62],7.457113923085106e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCN3,CCN family member 3,26603,25,4.45 [2.67-7.42],9.917439533859004e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCN4,CCN family member 4,26556,25,3.90 [2.20-6.89],2.8851092132751307e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCN5,CCN family member 5,26305,24,6.93 [3.67-13.11],2.575191830314164e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD14,Monocyte differentiation antigen CD14,25728,25,4.07 [2.36-7.01],4.362718817198885e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD200,OX-2 membrane glycoprotein,26303,23,4.72 [2.47-9.02],2.59911590960843e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD27,CD27 antigen,26391,24,7.01 [4.39-11.21],3.8582297909669104e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD274,Programmed cell death 1 ligand 1,26148,22,4.16 [2.59-6.70],4.385887000582873e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD300C,CMRF35-like molecule 6,26579,25,5.56 [2.71-11.39],2.808960236751796e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD300E,CMRF35-like molecule 2,26473,25,5.99 [3.31-10.85],3.2816914215117997e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD300LG,CMRF35-like molecule 9,26305,24,6.18 [2.81-13.60],5.980005796400243e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD302,CD302 antigen,26210,25,6.24 [3.46-11.25],1.0880660127012443e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD46,Membrane cofactor protein,26132,24,4.33 [2.58-7.26],2.7538525774111636e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD55,Complement decay-accelerating factor,25376,24,3.17 [1.93-5.21],5.06603144349238e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD59,CD59 glycoprotein,25321,24,8.24 [4.34-15.62],1.054128108149862e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,26579,25,8.77 [4.55-16.89],8.729385918986972e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD79B,B-cell antigen receptor complex-associated protein beta chain,26632,24,3.27 [2.06-5.19],5.516384266640445e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD83,CD83 antigen,26303,23,4.68 [2.37-9.22],8.17335039818314e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD93,Complement component C1q receptor,25291,25,6.68 [3.39-13.14],3.8975182189631256e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH1,Cadherin-1,25415,24,2.75 [1.91-3.96],5.26839063609255e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH17,Cadherin-17,26321,24,2.86 [1.94-4.20],9.279093726647734e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDNF,Cerebral dopamine neurotrophic factor,26210,25,2.89 [1.90-4.37],5.724399897712398e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,26321,24,9.65 [5.29-17.62],1.553888002713681e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHAD,Chondroadherin,22339,18,0.15 [0.07-0.31],1.879358044912314e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",22795,18,3.46 [2.13-5.61],5.36240152614896e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHGA,Chromogranin-A,22838,18,2.06 [1.50-2.83],8.192748506586438e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHGB,Secretogranin-1,26491,25,5.14 [3.05-8.67],8.760382119694693e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,26487,24,7.23 [3.93-13.27],1.8304227827908364e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CKB,Creatine kinase B-type,22838,18,5.59 [2.88-10.83],3.570015707803772e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,26321,24,5.19 [2.96-9.12],1.020411998338928e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,26642,25,9.40 [5.64-15.67],7.974264170055169e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CST3,Cystatin-C,26350,25,8.53 [4.38-16.64],3.0936410593926456e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,22838,18,9.81 [3.88-24.83],1.4218646273719769e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",26391,24,6.19 [3.01-12.70],6.826741386931574e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,26579,25,6.35 [3.07-13.14],6.352885801912458e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DPP6,Dipeptidyl aminopeptidase-like protein 6,26210,25,8.71 [3.71-20.47],6.929889643044813e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,26210,25,6.80 [3.46-13.37],2.7539570932054494e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,26556,25,8.93 [5.70-14.00],1.2742153130262365e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,26338,25,9.97 [4.88-20.33],2.6073775722919933e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EFNA4,Ephrin-A4,26105,22,8.97 [5.07-15.87],4.9743977298242574e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPHA2,Ephrin type-A receptor 2,25379,24,7.28 [4.43-11.96],4.5114314422613705e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPHB6,Ephrin type-B receptor 6,26105,22,9.65 [4.16-22.39],1.3132027250667758e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,26518,25,4.61 [2.44-8.73],2.60587641318206e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ESAM,Endothelial cell-selective adhesion molecule,26642,25,6.88 [3.74-12.66],5.50500803182774e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP1,"Fatty acid-binding protein, liver",26304,24,2.20 [1.67-2.89],1.4591716697922296e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP2,"Fatty acid-binding protein, intestinal",26321,24,2.30 [1.62-3.27],3.654417846198398e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",26642,25,3.36 [2.07-5.46],9.801045888378884e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FOLR1,Folate receptor alpha,26261,24,8.10 [3.95-16.61],1.1458659613173913e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FSTL1,Follistatin-related protein 1,22230,18,8.74 [3.47-22.03],4.282294213048896e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FSTL3,Follistatin-related protein 3,26266,24,8.91 [4.71-16.84],1.647951340429737e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",26210,25,5.57 [2.68-11.60],4.355443992708837e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GDF15,Growth/differentiation factor 15,26642,25,3.06 [2.37-3.96],1.6371194009871822e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,26148,22,5.86 [2.82-12.16],2.1243184385532352e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,22795,18,8.04 [3.62-17.88],3.188661999913538e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GPR37,Prosaposin receptor GPR37,25852,25,3.04 [1.91-4.83],2.699691928645353e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GRN,Progranulin,26172,24,5.79 [2.67-12.52],8.308092971931514e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GUCA2A,Guanylin,26183,24,7.27 [3.77-14.03],3.301880904486496e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,26523,25,3.65 [2.69-4.96],8.69495109003006e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,26305,24,6.45 [3.60-11.58],4.0298612393774487e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",26303,23,6.30 [2.86-13.87],4.9159203390658e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HSPB6,Heat shock protein beta-6,26556,25,5.72 [3.42-9.58],3.252707694393187e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,26091,24,6.02 [3.10-11.71],1.1914817156857752e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGF1R,Insulin-like growth factor 1 receptor,26210,25,3.49 [2.12-5.75],9.509395335166176e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,26590,25,6.06 [3.35-10.95],2.4238981436548676e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP3,Insulin-like growth factor-binding protein 3,26390,25,0.11 [0.06-0.23],6.898482492575854e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,25980,24,4.40 [3.01-6.43],2.2058064268640448e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP6,Insulin-like growth factor-binding protein 6,26187,25,5.54 [3.30-9.31],9.830163061681598e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,26442,24,3.97 [2.47-6.40],1.3789566191220075e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL18BP,Interleukin-18-binding protein,26390,25,7.29 [3.92-13.57],3.580146016402635e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL18R1,Interleukin-18 receptor 1,26632,24,7.73 [3.14-19.02],8.421929761142794e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,26543,25,5.85 [3.34-10.25],6.447273287279576e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,26140,25,3.85 [2.32-6.37],1.6812196343366996e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,26303,23,4.39 [2.47-7.81],4.933602108542133e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",INHBB,Inhibin beta B chain,22339,18,4.87 [2.62-9.06],5.712245434191896e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,26390,25,9.27 [4.08-21.05],1.0420377720209365e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KITLG,Kit ligand,26321,24,7.57 [3.27-17.56],2.38682182782549e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK11,Kallikrein-11,26137,24,4.08 [2.62-6.35],4.2553899043902757e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK4,Kallikrein-4,26556,25,2.87 [2.22-3.70],8.827768235464843e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",26269,23,2.62 [1.85-3.73],7.405330101554872e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAYN,Layilin,26105,22,9.63 [5.58-16.60],3.829309544488159e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LEPR,Leptin receptor,26321,24,3.50 [2.04-5.98],4.901095080796057e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGALS3,Galectin-3,26383,25,4.79 [2.42-9.48],6.662707471840256e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGALS4,Galectin-4,26304,24,5.04 [3.30-7.70],6.369370592807731e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LIFR,Leukemia inhibitory factor receptor,26303,23,7.02 [3.69-13.36],3.013118735116636e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,26289,24,6.27 [3.00-13.12],1.0694481795331148e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,26642,25,5.52 [2.75-11.11],1.6620642103733902e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP12,Macrophage metalloelastase,26364,25,4.90 [3.18-7.53],4.663013764944592e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP3,Stromelysin-1,26305,24,3.36 [2.20-5.13],2.15090992303146e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP7,Matrilysin,25810,25,5.45 [2.71-10.94],1.8951938629349927e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MUC13,Mucin-13,25715,25,3.98 [2.76-5.73],1.4339836129024564e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NCR1,Natural cytotoxicity triggering receptor 1,26267,23,8.81 [4.25-18.29],5.179222234771957e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,22768,18,6.30 [3.54-11.21],3.953193410208991e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NECTIN4,Nectin-4,26391,24,6.04 [3.81-9.57],1.8422678722257533e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NEFL,Neurofilament light polypeptide,25633,25,4.97 [3.51-7.02],1.3288622437210357e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,26391,24,0.19 [0.10-0.40],7.111319515854805e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NOS1,"Nitric oxide synthase, brain",25715,25,2.45 [1.70-3.54],1.661304881645312e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,26321,24,5.17 [3.17-8.44],4.770286856366826e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OGN,Mimecan,26305,24,7.30 [4.23-12.59],9.19281961494158e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PALM,Paralemmin-1,22648,17,5.92 [2.88-12.18],1.3317874152675274e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDCD1LG2,Programmed cell death 1 ligand 2,26210,25,5.47 [2.97-10.05],4.520341532497315e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PGF,Placenta growth factor,26632,24,3.21 [2.06-4.99],2.342466297489662e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,26148,22,8.98 [3.82-21.10],4.761848993385094e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PIGR,Polymeric immunoglobulin receptor,25975,24,4.70 [2.41-9.15],5.428113632044731e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,26305,24,5.86 [3.12-11.00],3.7295611481709494e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLIN3,Perilipin-3,26321,24,4.16 [2.40-7.23],4.1056274847265683e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTGDS,Prostaglandin-H2 D-isomerase,26102,24,6.93 [4.11-11.68],3.571332047173101e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,26056,22,4.59 [2.62-8.03],9.073375076773349e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",QPCT,Glutaminyl-peptide cyclotransferase,26313,25,7.85 [3.27-18.86],4.115861728223028e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,22816,18,2.77 [1.77-4.34],8.312524584803664e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RBP2,Retinol-binding protein 2,26210,25,2.82 [2.01-3.96],2.2960032858009958e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REG1A,Lithostathine-1-alpha,26154,25,3.87 [2.75-5.45],8.651855502942439e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REG1B,Lithostathine-1-beta,26642,25,2.76 [1.98-3.84],1.7293718465447112e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REG4,Regenerating islet-derived protein 4,26352,24,6.99 [4.26-11.45],1.2435346602905944e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,26305,24,7.49 [3.45-16.29],3.673383956433949e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REN,Renin,26321,24,4.11 [3.20-5.28],1.1477000729696967e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNASET2,Ribonuclease T2,26500,25,6.94 [3.69-13.08],2.009247086841699e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RSPO3,R-spondin-3,26556,25,6.79 [3.34-13.78],1.157684738159004e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCARB2,Lysosome membrane protein 2,25640,22,6.50 [3.66-11.56],1.8132918752580367e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCGN,Secretagogin,25838,23,3.14 [1.94-5.08],3.3501270115290074e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,26254,24,7.31 [3.85-13.90],1.2905351169233395e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SMOC1,SPARC-related modular calcium-binding protein 1,26556,25,5.44 [2.70-10.95],2.08182323318355e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,26442,24,4.40 [2.62-7.42],2.470139901048034e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,25697,25,7.25 [4.15-12.66],3.4442946467717018e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,26305,24,4.12 [2.74-6.21],1.1318904541639395e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,26303,23,3.18 [2.19-4.62],1.249698790136614e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPON1,Spondin-1,26352,24,5.06 [2.91-8.78],8.270373370399116e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,26210,25,7.18 [4.34-11.88],1.594178864187075e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TCN2,Transcobalamin-2,26590,25,4.41 [2.65-7.35],1.1272975222570544e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TFF1,Trefoil factor 1,26183,24,2.16 [1.57-2.98],2.7235353158403326e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TFF2,Trefoil factor 2,26401,24,2.59 [1.73-3.89],4.254550656339787e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TGFBR2,TGF-beta receptor type-2,26391,24,9.67 [5.92-15.80],1.1847438357648606e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TGFBR3,Transforming growth factor beta receptor type 3,26642,25,8.87 [3.74-21.04],7.458590971168729e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",THY1,Thy-1 membrane glycoprotein,26579,25,8.92 [3.82-20.84],4.29261242477244e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,26632,24,8.10 [4.83-13.59],2.0546859708713026e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,26391,24,6.70 [3.67-12.23],5.724051597158026e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,26556,25,6.32 [3.62-11.06],1.0157241348307536e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,26305,24,2.56 [1.93-3.40],6.267102959782965e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,26584,24,4.67 [2.93-7.44],9.184335017186188e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,26148,22,3.45 [2.40-4.95],2.536284850033985e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",UMOD,Uromodulin,26548,24,0.33 [0.20-0.53],6.84740099652339e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VASN,Vasorin,25888,24,6.91 [3.29-14.52],3.337474502114508e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,22744,18,3.39 [2.15-5.33],1.3385544192721784e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,26269,24,6.21 [3.93-9.79],4.298858808604253e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VWC2,Brorin,26062,22,6.51 [3.09-13.69],7.990773464724925e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,24957,22,6.92 [4.41-10.85],3.961984489215596e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WNT9A,Protein Wnt-9a,25838,23,4.68 [2.73-8.00],1.7828520900461022e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",XG,Glycoprotein Xg,26504,25,4.65 [2.55-8.47],5.16268311347271e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",YAP1,Transcriptional coactivator YAP1,22795,18,7.68 [3.55-16.64],2.2821183568013658e-07
